source
- BIO proposes seven-point plan to keep US biotech ahead of ChinaBIO, a major biotech lobbying organization, released a seven‑part “BioAdvance” action plan aimed at preserving U.S. leadership in biotechnology as China rolls out its own five‑year strategy. The p…
- Democratic committee chairs send letters to 27 drugmakers demanding details on Trump-era MFN pricing agreementsIncoming Democratic chairs of the Senate Finance Committee and the House Energy and Commerce, Ways and Means, and Education and Labor committees have issued a new round of letters to all 27 drugmak…